Biogen CEO: Want to stop inversions? Reform tax code

CNBC's Meg Tirrell speaks to Dr. George Scangos, Biogen Idec CEO, about the company's Q2 earnings surge, drug pipeline, and America's tax code. Scangos says we need a corporate tax rate that is competitive with rest of the world and a territorial tax system.
03:34
Wed, Jul 23 201411:45 AM EST